Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry-Reference-Cited by-同舟云学术

Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry

Published:2022-11 Issue: Volume:45 Page:12-22
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Bjartell Anders,Costa Luis,Kramer Gero,Zurawski Bogdan,Galli Luca,Werbrouck Patrick,Ecke Thorsten,Parikh Omi,Bennamoun Mostefa,Garcia Freire Camilo,Peer Avivit,Ljungberg Börje,Cicin Irfan,Smith Emma,Lukac Martin,Wapenaar Robert,Chowdhury Simon

Publisher

Elsevier BV

Subject

Urology

Reference15 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. World Health Organization International Agency for Research on Cancer. Cancer today: prostate cancer. 2020. https://gco.iarc.fr/today/home.

3. Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline;Basch;J Clin Oncol,2014

4. Sequencing of agents in castration-resistant prostate cancer;Lorente;Lancet Oncol,2015

5. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology;Nuhn;Eur Urol,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azolato-Bridged Dinuclear Platinum(II) Complexes Exhibit Androgen Receptor-Mediated Anti-Prostate Cancer Activity;Inorganic Chemistry;2024-09-11

2. Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer Patients;European Urology Open Science;2024-08

3. Impact of Novel Agents on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer;Anticancer Research;2024-06-26

4. Therapiesequenzen und –dauer beim mCRPC: Eine retrospektive Aufarbeitung der Lübecker mCRPC-Kohorte;Aktuelle Urologie;2024-06-25

5. Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform;European Urology Open Science;2024-05